Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic...
Day: August 20, 2025
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is...
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
Study met primary endpoint demonstrating barzolvolimab’s ability to potently deplete mast cells in the gastrointestinal tractProfound mast cell depletion did...
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15,...
Ligand to Participate in September Investor Conferences
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd...
Arcutis to Present at Upcoming Investor Conferences
WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing...
NMDP Announces Nationwide Celebration and Fundraiser to Help Patients in Need of Life-Saving Cell Therapy
NMDP Unite will be held simultaneously on Sept. 20—World Marrow Donor Day—in Atlanta, Houston, New York, Minneapolis and Seattle Be...
REPEAT — Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) --...
Adia Med Expands Into Wound Care, Targeting High-Demand $25 Billion Market and Unlocking New Growth Avenues
Winter Park, Florida--(Newsfile Corp. - August 20, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company at the...
Hemostemix’s Social Media for Investors and Florida’s No-Option Patients
Calgary, Alberta--(Newsfile Corp. - August 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
AI-Powered Pathogen Detection App: Provisional Patent Filed by FendX CEO
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company"...
DEA Unconstitutional Marijuana Playbook: How the DEA Is Repeating the DOL’s Mistakes Against MMJ BioPharma
"Two Federal Agencies, One Unconstitutional Playbook, all While Agency Overreach Crushes a 125 year old Family Farm and Paralyzes a...
Alomone Labs Integrates Bioz Pro Badges and a Bioz Content Hub to Elevate Research Visibility and Enhance the User Experience
PALO ALTO, CALIFORNIA / ACCESS Newswire / August 20, 2025 / Bioz, Inc., a trusted source for AI-enhanced research insights...
BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline
VANCOUVER, BC / ACCESS Newswire / August 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a...
ANGLE Announces Collaboration with Myriad Genetics
Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test...
Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology
BEIJING, Aug. 19, 2025 /PRNewswire/ -- From August 15-17, the 31st China International Medical Equipment Exhibition and Scientific Conference (China-Hospeq...